DUBLIN--(BUSINESS WIRE)--The "Penile Implants or Penile Prosthesis Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2015-2023" report has been added to Research and Markets' offering.
The global market for penile implants was valued at around USD 232 million in 2016 and is expected to reach around USD 270 million by 2023, growing at a CAGR of around 2.1% during the forecast period of 2017 to 2023.
Erectile Dysfunction (ED) and Premature Eejaculation (PE) are the two most prevalent male sexual dysfunctions. Chances of sexual dysfunction increases with age, physical inactivity, smoking, diabetes, stress and prostate concerns. Erectile dysfunction is estimated to affect more than 150 million men worldwide and the number of men with ED is expected to double by the year 2030. Although most cases are not reported, it is estimated that more than 30 million men affected in the United States.
Rise in base of population with sexual disorders, changing lifestyle habits such as smoking, and drinking alcohol and increasing stress levels in the men due to the work life are some of the driving factors of this market. In addition, large number of drugs under pipeline for FDA approval, emerging next generation erectile dysfunction therapies, continued adoption of improved penile implant systems, launch of various low cost generic drugs, and introduction of novel techniques are further expected to boost the market growth in the coming years.
Companies Mentioned:
- American Medical Systems (Boston Scientific)
- Coloplast
- Silimed
- Giant Medical
- Eska Medical Gmbh
- Promedon
- Zephyr Surgical Implants
Key Topics Covered:
1 Scope of the report
2 Executive summary
3 Qualitative analysis
4 Global penile implants market, by type, 2015 - 2023
5 Global penile implants market, by geography, 2015 - 2023
6 Company profiles
For more information about this report visit https://www.researchandmarkets.com/research/jw7tq9/penile_implants
